Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?

    March 2016 in “ The Journal of Obstetrics and Gynecology of India ”
    Suvarna Khadilkar
    Image of study
    TLDR The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.
    The 2016 review article proposed renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) to better reflect the condition's characteristics. The term PCOS was deemed misleading as it inaccurately suggests the presence of ovarian cysts and fails to represent the hyperandrogenism and metabolic derangements associated with the condition. The article also highlighted inconsistencies in the diagnostic criteria for PCOS across different statements, such as the Rotterdam 2003, AES 2006, and NIH 1990. The proposed name, HA-PODS, was aimed at facilitating diagnosis, treatment, and research consistency. The document also discussed the prevalence and risk factors of type 2 diabetes mellitus, impaired glucose tolerance, metabolic syndrome, and depressive disorders in women with PCOS. However, no conclusion was reached on a new name for PCOS, indicating ongoing discussion in the scientific community.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 22 results

      community PCOS Hair Loss: What’s Helped Me (and What Didn’t)

      in Treatment  11 upvotes 6 months ago
      OP shares their experience with PCOS-related hair loss, highlighting that addressing vitamin D and ferritin deficiencies, managing hormones with spironolactone, and using gentle hair care products helped improve their condition. They advise against relying on "miracle" hair oils and emphasize the importance of medical evaluation and a combined approach to treatment.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  54 upvotes 2 years ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community I think this is my stop, gentlepeople. So long and thanks for all the data 👋

      in Transgender  2259 upvotes 8 months ago
      A user shared their successful experience with hair regrowth and transitioning from male to female using minoxidil, finasteride, Nutrafol, microneedling, and hormone replacement therapy (HRT). They expressed gratitude for the results and encouraged others to explore treatments that align with their personal goals.

      community Bryan Johnson just dropped his anti hair loss formula

      in Treatment  338 upvotes 2 years ago
      Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.

    Similar Research

    5 / 1000+ results